Sponsored by:

Heart Failure Association of the European Society of Cardiology

Heart Failure Congress | May 21-24, 2011

Heart Failure Congress 2011
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Monday May 23 2011

  • Benefit for Some HF Patients in Telemonitoring

    GOTHENBURG, Sweden — Remote monitoring doesn't boost heart failure clinical outcomes for patients overall but may help in newly diagnosed or unstable cases, researchers found in two clinical trials.

  • Heart Rate Drug Offers Modest Uptick in QOL

    GOTHENBURG, Sweden — Reducing heart rate with ivabradine (Procoralan) modestly improves how patients feel with heart failure, according to a SHIFT trial substudy.

  • Diuretic Prevents Atrial Arrhythmias in HF

    GOTHENBURG, Sweden — The selective aldosterone-receptor blocker eplerenone (Inspra) reduces incidence of atrial fibrillation or flutter in mildly symptomatic systolic heart failure patients, according to an EMPHASIS-HF subanalysis.

Sunday May 22 2011

  • Higher Heart Rate Acts as Prognostic Marker

    GOTHENBURG, Sweden — A rapid heart rate in chronic heart failure patients carries a higher mortality risk regardless of ejection fraction status, but also predicts a modest survival benefit from candesartan (Atacand), researchers found.

  • Mitral Valve Clip Viable When Surgery Too Risky

    GOTHENBURG, Sweden — Percutaneous mitral valve repair appears to benefit patients at high surgical risk, a case-control analysis within the EVEREST II trial suggested.

Friday May 20 2011

  • Comorbidities Take Focus in Heart Failure

    GOTHENBURG, Sweden — Comorbidities and context will take the spotlight at the Heart Failure Congress meeting here.